EASD Study Groups
EASD Study Groups
Artificial Insulin Delivery, Pancreas and Islet Transplantation Study Group (AIDPIT)
The AIDPIT Study Group addresses key research areas, that offer the most progress in comparison to current treatment options:
Biomedical Imaging in Diabetes Study Group (DIAB IMAGE)
The aim of the Study Group is to further research and education in biomedical imaging in all type of diabetes, but mainly Type 1 Diabetes and Type 2 Diabetes (T1D/ T2D). Particularly, DIAB IMAGE aims to foster the use of biomedical imaging in T1D and T2D, exploit complimentary expertise between diabetologists, imaging experts and researchers in related fields, build up networks across the related disciplines, defining the most important scientific questions that need to be addressed and help to define European science policy in respect to imaging in diabetes.
Diabetes and Cancer Study Group (DCSG)
There has been a recent surge of interest in the potential associations between diabetes, diabetes treatments and cancer risk, backed by confirmation that a mounting number of cancer types are associated with type 2 diabetes.
Diabetes Education Study Group (DESG)
The aims of the DESG are to encourage and support therapeutic education about diabetes and the rapid diffusion of acquired scientific knowledge in the field.
Diabetes Pregnancy Study Group (DPSG)
The aims of the DPSG are to improve the detection and management of diabetes in pregnant women and their offspring by fostering research, treatment and education in the subject of diabetic pregnancy.
Exercise and Physical Activity Study Group (ExPAS)
The aim of the Study Group is to promote communication, scientific collaborations and clinical education in the areas that link exercise sciences to metabolism and diabetes.
Reactive Metabolites in Diabetes Study Group (RM)
The major focus of the Study Group is to define the role of reactive metabolites, such as reactive oxygen species (ROS) and reactive carbonyl species (RCS), in diabetes, especially the role in promoting late diabetic complications. Understanding the formation of those metabolites and the molecular mechanism(s) of their action with respect to late complications will facilitate the development of new diagnostic but also therapeutic strategies.
Non-alcoholic fatty liver disease (NAFLD)
NAFLD is currently the most common liver disorder both in the US and Europe. The fatty liver may progress to non-alcoholic steatohepatitis (NASH), which markedly increases the risk of cirrhosis and hepatocellular carcinoma. NAFLD is the hepatic manifestation of the metabolic syndrome and characterizes the majority of patients with type 2 diabetes.
Diabetes Neuropathy Study Group (NEURODIAB)
NEURODIAB is a study group of the European Association for the Study of Diabetes (EASD) with special responsibility for Diabetic Neuropathy. Its aim is to promote the advance of knowledge on all aspects of diabetic neuropathy through an active cooperation between interested diabetologists and other specialists such as neurologists, neurophysiologists, urologists, gastroenterologists, etc. In pursuit of this aim it will also encourage appropriate surveys and clinical trials.
Eye Complications Study Group (EASDec)
EASDec is a study group of the European Association for the Study of Diabetes (EASD) with special responsibility for all eye complications of diabetes. Its aim is to promote the advancement of knowledge on all aspects of diabetic retinopathy, including epidemiology, pathology, pathophysiology, imaging, prevention and treatment through an active cooperation between ophthalmologists, diabetologists and a wide range of laboratory and clinical scientists.
The ultimate goal of the Group is to search for the best treatment for diabetic retinopathy to prevent the development of visual impairment in people with diabetes.
European Diabetic Nephropathy Study Group (EDNSG)
The Diabetic Nephropathy Study Group of the EASD is established with the aim of assembling researchers interested in diabetic renal disease in order to study epidemiology, pathology, pathophysiology and treatment of this complication of diabetes mellitus. The ultimate goal of the Group is to prevent the appearance or the development of kidney disease and to search far the best treatment of this condition in diabetic patients.
33rd EDNSG Annual Meeting, 22-23 May 2020 in Glasgow, UK more
Incretin Study Group
The overall goal of the INCRETIN Study Group is to confront knowledge and ideas related to incretin physiology and clinical applications with the aim to identify key questions that need to be addressed in clinical and fundamental science and propose key clinical trials; to diffuse news and organize meetings about incretins and related topics. These goals are achieved through organization of round tables discussions, which take place every other year, to discuss what is “known, new, controversial” in the incretin field.
Islet Study Group
The EASD Islet Study Group arose from discussions of participants of the islet meeting held at Coleraine 15-18 September 1991. Since this time, the Group has held meetings annually in close association with the main EASD Congress. Approximately 120 participants attend each meeting, which are of 2-days duration.
European Diabetes Epidemiology Group (EDEG)
The goal of the group is to lead and facilitate epidemiological research on disorders of glucose tolerance and its complications and to act as a forum for interchange and dissemination of findings.
Diabetes and Nutrition Study Group
Aims of the DNSG are to promote scientific interchange on clinical and metabolic effects of nutrition in relation to diabetes and the implementation of appropriate dietary therapy in individuals with diabetes.
Psychosocial Aspects of Diabetes Study Group (PSAD)
The aims of the PSAD Study Group are:
Diabetic Foot Study Group (DFSG)
The aim of the Diabetic Foot Study Group of the European Association for the Study of Diabetes is to promote an advancement of knowledge on all aspects of diabetic foot care through active co-operation and collaboration between diabetologists, podiatrists, specialist nurses, orthopaedic and vascular surgeons and all other specialists with an interest in caring for diabetic patients with foot problems.
Study Group on Primary Care Research in Diabetology (PCDE)
PCD Europe exists to provide a focal point for primary care clinicians and their patients. Its purpose is to promote high standards of care throughout Europe. Emphasis is placed on incorporating evidence-based medicine into daily practice as well as promoting diabetes education and research in primary care.
Study Group on Genetics of Diabetes (SGGD)
Aim: To promote research into the genetic basis of all forms of diabetes (and related conditions), as well as to promote the interaction and transfer of knowledge between basic scientists and the clinical community.
Diabetes and Cardiovascular Disease Study Group
European Group for the Study of Insulin Resistance (EGIR)
The aim of the EGIR group is to study insulin resistance and its relationship with beta cell function, risk of cardiovascular disease, diabetes and other metabolic diseases.
International Hypoglycaemia Study Group (IHSG)
The IHSG’s overarching goal is to improve the lives of people with diabetes. To this end, the IHSG will pursue the following key objectives:
The IHSG will engage in a variety of professional scientific communications endeavours (e.g., publications, symposia, continuing medical education) to achieve these objectives.
Health Services Research and Health Economics Study Group
The group is aiming at consolidating already existing research initiatives in economic aspects of clinical- and cost-effectiveness in routine care, efficiency of clinical research studies or interventions with emphasis on patient-centeredness. The group is going to establish joint research projects in an effort to further develop the link between basic science, clinical science and health service research studies.
Study Group on Metabolic Surgery